Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Curocell, based in Daejeon, South Korea, is clinical-stage biotech innovating CAR-T therapies. Curocell is developing OVIS™ CAR-T therapies with the goal of reducing non-responding patients who receive CAR-T therapy. Curocell established a GMP facility in Samsung Medical Center, one of the largest cancer centers in Asia with 655 beds.

List your booth number for exhibitions, ask us